CXCL2 and breast cancer: Similarly, CXCL1 and CXCL2 secretion by breast cancer cells resulted in increased infiltration of pro-tumorigenic myeloid cells and was further augmented by chemotherapeutic treatment, leading to chemoresistence (16).